Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4846 AL 4860

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Bukhari SN, Jantan I.

Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.

Alzheimer's disease: a report from the 7th Kuopio Alzheimer symposium

Haapasalo A, Pikkarainen M, Soininen H.

Neurodegener Dis Manag. 2015 Oct;5(5):379-82. doi: 10.2217/nmt.15.31. Epub 2015 Oct 19.

The potential of virtual reality-based training to enhance the functional autonomy of Alzheimer's disease patients in cooking activities: A single case study

Foloppe DA, Richard P, Yamaguchi T, Etcharry-Bouyx F, Allain P.

Neuropsychol Rehabil. 2018 Jul;28(5):709-733. doi: 10.1080/09602011.2015.1094394. Epub 2015 Oct 20.

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.

Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.

[A comparison of the efficacy and safety of memantal and original memantine in the treatment of mild and moderate dementia in Alzheimer's disease]

Shiryaev OY, Shapovalov DL, Polozova TM, Goncharova OV, Kuznetsova NA, Cherenkova EV, Fedorova EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):56-61. doi: 10.17116/jnevro201511510156-61.

Novel potential for the management of Alzheimer disease

Ginter E, Simko V, Weinrebova D, Ladecka Z.

Bratisl Lek Listy. 2015;116(10):580-1. doi: 10.4149/bll_2015_112.

Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial

Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR.

Neurology. 2015 Dec 1;85(22):1937-44. doi: 10.1212/WNL.0000000000002171. Epub 2015 Nov 4.

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease

Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.

Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.

Alzheimer dementia--a problem of individuals, families, medicine and society

Kostić S.

Vojnosanit Pregl. 2015 Sep;72(9):763-4. doi: 10.2298/vsp1509763k.

The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients

Yang SY, Shan CL, Qing H, Wang W, Zhu Y, Yin MM, Machado S, Yuan TF, Wu T.

CNS Neurol Disord Drug Targets. 2015;14(10):1292-7. doi: 10.2174/1871527315666151111123319.

Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?

Portugal EM, Vasconcelos PG, Souza R, Lattari E, Monteiro-Junior RS, Machado S, Deslandes AC.

CNS Neurol Disord Drug Targets. 2015;14(9):1209-13. doi: 10.2174/1871527315666151111121749.

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy

Ashraf GM, Tabrez S, Jabir NR, Firoz CK, Ahmad S, Hassan I, Alexiou A, Kamal MA.

Curr Drug Metab. 2015;16(8):719-27. doi: 10.2174/138920021608151107125757.

The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease

Ishikawa I, Shinno H, Ando N, Mori T, Nakamura Y.

Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61. Epub 2015 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias